Introduction In FY 2026, U.S. market access for medical devices is being defined by execution on fundamentals like Establishment Registration, Device Listing, user‑fee planning, and timely Small Business Determination, rather than by classification alone. Once the regulatory pathway is determined, registration and listing are to be treated as non-negotiable infrastructure, with roles and timing assigned [...]